Results for “ ”

Entry Author Date Location
Incyte, Merck Cancer Trial Failure Damages IDO Drugs’ Prospects 04/06/18 National
BioCrossroads Report: Life Science Sector Thriving, With Room to Grow 04/06/18 Indiana
Xconomy Giveaway: 20 Tickets for Startups at Big Data Meets Big Bio 04/06/18 National
Unity Biotech Files IPO to Bring Anti-Aging Drugs into Clinical Trials 04/06/18 San Francisco
Bio Roundup: Ex-Kiters Say Allo, NASH Cash & Data, Alkermes No & More 04/06/18 National
Arcturus Proxy Fight Heats Up; Ex-CEO Responds to Board’s Charges 04/06/18 San Diego
Nutrition-Focused GenoPalate Joins Crowd of DNA Test Kit Companies 04/05/18 Wisconsin
Conatus Pharma’s Liver Disease Drug Flunks First Phase 2 Test 04/05/18 San Diego
Lilly Licenses Sigilon’s Cell Encapsulation Tech for Diabetes Therapy 04/04/18 Boston
Fatty Liver Disease Now Global, Terns Pharma Aims for NASH in China 04/04/18 San Francisco
Virta Health Hauls in $45M to Expand “Diabetes-Reversing” Software 04/04/18 San Francisco
Roche Buys Inception 5 MS Program, Versant Funds New Venture 04/04/18 San Diego
Ex-Kite Execs Resurface with $300M and Control of Pfizer CAR-T Cells 04/03/18 San Francisco
Boston Scientific Buys Securus for $40M to Add to Heart Imaging Lineup 04/03/18 Boston
Macrolide Pharma Raises $20M, Names Former Intarcia Exec Karande CEO 04/02/18 Boston
FDA Refuses Review of Alkermes Depression Drug, Wants More Trials 04/02/18 Boston
Straight Outta Wisconsin, LynxBio Wins EvoNexus Best Demo Vote 04/02/18 San Diego
Bio Roundup: Biotech IPOs, Migraine Progress, Takeda Woos Shire & More 03/30/18 National
Arcturus Board Sues Ex-CEO, Alleges Deceit, in Prelude to Proxy Fight 03/29/18 San Diego
Get the Inside Scoop on Seattle Life Sciences at Xconomy’s June Event 03/29/18 National
Unum Therapeutics IPO Raises $69M to Test Universal Cell Therapies 03/29/18 Boston
Edge to Cut Jobs as Head Injury Drug Flops in Phase 3, Shares Tumble 03/28/18 New York
Tempest Therapeutics Debuts with $70M to Bring Cancer Drugs to Clinic 03/28/18 San Francisco
No Data Yet, But Homology Upsizes IPO and Raises $144M 03/28/18 Boston
EY Report Suggests Improving Conditions for U.S. IPOs in 2018 03/26/18 National
Surface Oncology Plans IPO to Advance Clinical Tests of Cancer Drug 03/26/18 Boston
Racing Allergan, Biohaven Touts Migraine Drug Data, But Shares Sink 03/26/18 New York
Auris Health’s Surgical Robot Gets FDA Green Light for Lung Cancer 03/23/18 San Francisco
Bio Roundup: CMS Backs Cancer Tests, Right to Try Passes, AbbVie Sinks 03/23/18 National
AbbVie Shares Plummet as $5.8B Bet on Stemcentrx Takes a Hit 03/22/18 National
Page 2 of 344 « previous page · next page »